TrialBMC gastroenterology2014

Dose-dependent effects of lesogaberan on reflux measures in patients with refractory gastroesophageal reflux disease: a randomized, placebo-controlled study.

Philip B Miner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.